Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT00376181 · TERMINATED

Trial details

NCT number: NCT00376181
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2006-06-01
Primary completion: 2007-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.